enGene Therapeutics Inc. (ENGN)
Biological Products, (No Diagnostic Substances) · Healthcare · $117M
Intrinsic Value (Consensus)
$0.00
Current Price
$1.75
Margin of Safety
0%
At Fair Value
Value: $0
Price: $2
Valuation Model Estimates
Current Price: $1.75
DCF (Discounted Cash Flow)
$85.91
Graham Number
$11.36
Earnings Power Value
$22.23
Relative Value (P/E)
$45.80
Dividend Discount Model
Not applicable
—
Consensus Value
$0.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
39
Profitability
10/25
Strength
7/25
Valuation
12/25
Growth
10/25
Financial Health Signals
Negative return on equity — company is losing money on shareholder capital
Negative free cash flow — company is burning cash
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $2.29
- EPS (Forward)
- $2.75
- Book Value
- $2.50
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- -69.9%
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance